PF-AtlasClinical Trials › NCT07686562

Artificial Intelligence Detection of Incidental Interstitial Opacity on Chest Radiography

VUNO Med®-Chest X-ray™ · Not specified

Registry ID
NCT07686562
Phase
Not specified
Status
Completed
Drug / intervention
VUNO Med®-Chest X-ray™
Sponsor
Chung-Ang University Hospital
Start
2022-02-01
Enrollment
1293
Locations
1

About this trial

The goal of this observational study is to learn how well an artificial intelligence (AI)-based chest X-ray analysis software can incidentally detect interstitial lung disease (ILD), which appears as interstitial opacity, on chest X-rays taken for other reasons, and whether these AI-flagged findings represent true interstitial opacity. The main question it aims to answer is: How often does an AI-flagged interstitial opacity correspond to true ILD? This retrospective study uses existing records: researchers review each participant's follow-up computed tomography(CT), CT report, and final diagnosis to confirm true ILD and reticular opacity.

View NCT07686562 on ClinicalTrials.gov →

Explore related

Medical disclaimer. This page summarizes public trial data for NCT07686562 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.